Clinical Trial Update: Blue-Blocking IOLs in Combined Surgery [NA]

View source ↗

Summary

A completed clinical trial evaluated blue-blocking intraocular lenses used in combined cataract and retinal surgery for conditions including epiretinal membrane…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Epiretinal Membrane
• Macular Hole

Drugs mentioned

• Blue-blocking intraocular lenses

Snippet

Sponsor: The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | Conditions: Epiretinal Membranes, Macular Holes | NA | Status: COMPLETED